# Laryngeal Mask Airway (LMA) for Surfactant Administration in Neonates

> **NCT01116921** · NA · COMPLETED · sponsor: **University of Minnesota** · enrollment: 103 (actual)

## Conditions studied

- Respiratory Distress Syndrome

## Interventions

- **DEVICE:** Nasal continuous positive airway pressure (nCPAP)
- **DEVICE:** Laryngeal Mask Airway (LMA) to deliver surfactant
- **DRUG:** Surfactants, Pulmonary

## Key facts

- **NCT ID:** NCT01116921
- **Lead sponsor:** University of Minnesota
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-02
- **Primary completion:** 2015-04
- **Final completion:** 2015-04
- **Target enrollment:** 103 (ACTUAL)
- **Last updated:** 2017-02-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01116921

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01116921, "Laryngeal Mask Airway (LMA) for Surfactant Administration in Neonates". Retrieved via AI Analytics 2026-07-27 from https://api.ai-analytics.org/clinical/NCT01116921. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*